Lilly's Obesity Pill Reaches 4,000 Prescriptions in Second Week

Eli Lilly's new obesity treatment pill has reached approximately 4,000 prescriptions in its second week on the market, indicating strong early demand. The company notes that the oral medication is being rapidly adopted as an effective weight loss option. According to Reuters, Lilly's obesity pill offers the advantage of easier use compared to injection-based competitors. The prescription count nearly doubled from the first week to 4,000 in the second week, highlighting growing interest in oral obesity treatments. Analysts believe this rapid prescription growth could strengthen Lilly's position in the obesity market. The company continues to invest in expanding production capacity. However, the drug's long-term success will depend on factors such as clinical outcomes and side effect profiles. This is not investment advice.

📊 GOOGL — Piyasa Yorumu

▲ up · 30%

The news headline is not directly related to GOOGL, so its impact may be limited. Technical indicators point to a mild bullish trend: RSI at 61 is in neutral territory, MACD is below the signal line but positive, and the price is above the 20- and 50-day moving averages. The 2.8% increase over the last 24 hours supports short-term momentum. However, given the potential sectoral impact of the news and the lack of a clear technical signal, I assess a low-confidence bullish bias.

RSI 14

61.1

MACD

2.56

24h Δ

2.79%

📊 LLY — Piyasa Yorumu

▲ up · 60%

The news indicates that Lilly's obesity pill has reached 4,000 prescriptions in its second week, suggesting strong demand that may exceed market expectations. On the technical side, the RSI at 41 is near oversold territory, and the MACD is above its signal line, pointing to potential short-term recovery. However, with the price below both the SMA20 and SMA50, upside movement may be limited. Overall, the positive news combined with technical indicators suggests a possible upward move in the short term.

RSI 14

41.2

MACD

-8.92

24h Δ

-4.71%

Canlı Grafikler